These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6821224)

  • 1. Leukotrienes: a new approach to the biochemistry of hypersensitivity.
    Sirois P; Borgeat P
    Surv Immunol Res; 1982; 1(3):279-85. PubMed ID: 6821224
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of leukotrienes with cyclo-oxygenase products in guinea pig isolated trachea.
    Piper PJ; Tippins JR
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():183-5. PubMed ID: 6211950
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leukotrienes and the cardiovascular system].
    Sagach VF
    Patol Fiziol Eksp Ter; 1986; (1):84-9. PubMed ID: 3010220
    [No Abstract]   [Full Text] [Related]  

  • 4. Formation and actions of leukotrienes.
    Piper PJ
    Physiol Rev; 1984 Apr; 64(2):744-61. PubMed ID: 6324254
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between the myotropic activity of leukotriene A4 on guinea-pig lung, trachea and ileum and its biotransformation in situ.
    Sirois P; Brousseau Y; Salari H; Borgeat P
    Prostaglandins; 1985 Jul; 30(1):21-36. PubMed ID: 2996055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antagonists of leukotrienes: ONO-RS-411 and ONO-RS-347.
    Obata T; Katsube N; Miyamoto T; Toda M; Okegawa T; Nakai H; Kosuge S; Konno M; Arai Y; Kawasaki A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():229-31. PubMed ID: 2936099
    [No Abstract]   [Full Text] [Related]  

  • 7. Leukotrienes: mediators of inflammation and immediate hypersensitivity reactions.
    Malmsten CL
    Crit Rev Immunol; 1984; 4(4):307-34. PubMed ID: 6325090
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological studies on the novel antiallergic drug HQL-79: II. Elucidation of mechanisms for antiallergic and antiasthmatic effects.
    Matsushita N; Aritake K; Takada A; Hizue M; Hayashi K; Mitsui K; Hayashi M; Hirotsu I; Kimura Y; Tani T; Nakajima H
    Jpn J Pharmacol; 1998 Sep; 78(1):11-22. PubMed ID: 9804057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukotrienes].
    Dobrosotskaia LV; Shcherbak IG
    Ukr Biokhim Zh (1978); 1984; 56(4):452-60. PubMed ID: 6093306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins, slow-reacting substances (leukotrienes) and the lung.
    Seale JP
    Aust N Z J Med; 1981 Oct; 11(5):550-7. PubMed ID: 6798958
    [No Abstract]   [Full Text] [Related]  

  • 11. Biology of the C-6-sulfidopeptide leukotrienes.
    Lewis RA; Lee CW; Levine L; Morgan RA; Weiss JW; Drazen JM; Oh H; Hoover D; Corey EJ; Austen KF
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():15-26. PubMed ID: 6221518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bronchial asthma and prostaglandin related substances].
    Tomioka H
    Nihon Rinsho; 1985 Mar; 43(3):563-9. PubMed ID: 2989586
    [No Abstract]   [Full Text] [Related]  

  • 13. The mechanism of action of leukotrienes C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of guinea pig, rabbit and rat.
    Piper PJ; Samhoun MN
    Prostaglandins; 1981 May; 21(5):793-803. PubMed ID: 6122236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiological and pharmacological actions of prostaglandins and related substances: inflammation and allergy].
    Makino S
    Nihon Rinsho; 1985 Mar; 43(3):523-8. PubMed ID: 2989584
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of leukotrienes in asthma.
    Leitch AG
    Ann Acad Med Singap; 1985 Jul; 14(3):503-7. PubMed ID: 3000271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfone.
    Denis D; Charleson S; Rackham A; Jones TR; Ford-Hutchinson AW; Lord A; Cirino M; Girard Y; Larue M; Rokach J
    Prostaglandins; 1982 Dec; 24(6):801-14. PubMed ID: 6300970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and pharmacological characterization of 5-(2-dodecylphenyl)-4,6-dithianonanedioic acid and 5-[2-(8-phenyloctyl)phenyl]-4,6-dithianonanedioic acid: prototypes of a novel class of leukotriene antagonists.
    Perchonock CD; McCarthy ME; Erhard KF; Gleason JG; Wasserman MA; Muccitelli RM; DeVan JF; Tucker SS; Vickery LM; Kirchner T
    J Med Chem; 1985 Sep; 28(9):1145-7. PubMed ID: 2993610
    [No Abstract]   [Full Text] [Related]  

  • 18. ["Slow reacting substance of anaphylaxis": biochemical characterization and new prospects for the treatment of asthma and other allergic diseases (author's transl)].
    Boeynaems JM; Delespesse G
    Rev Med Brux; 1981 Nov; 2(9):803-9. PubMed ID: 6798664
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-([4- (1H-tetrazol-5-ylmethyl)phenoxy]methyl) phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4.
    Fleisch JH; Rinkema LE; Haisch KD; McCullough D; Carr FP; Dillard RD
    Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):70-7. PubMed ID: 3016562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure elucidation of leukotrienes.
    Marfat A; Corey EJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():155-228. PubMed ID: 2992244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.